DaVita (DVA) Tops Q2 EPS by 2c
Tweet
Share
E-mail
Get Alerts DVA Hot Sheet
Price: $181.33 -0.92%
Revenue Growth %: +2.6%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +2.6%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q2 EPS of $0.92, $0.02 better than the analyst estimate of $0.90. Revenue for the quarter came in at $3.88 billion versus the consensus estimate of $3.83 billion.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Cooper Cos. (COO) Tops Q3 EPS by 3c, Offers Guidance
- Copart (CPRT) Misses Q4 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
